Analysis of the severity of dyskinesia in patients with Parkinson's disease via wearable sensors

被引:0
作者
Patel, Shyamal [1 ]
Sherrill, Delsey
Hughes, Richard
Hester, Todd
Huggins, Nancy
Lie-Nemeth, Theresa
Standaert, David
Bonato, Paolo
机构
[1] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept PM&R, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA
[3] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA
来源
BSN 2006: INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS | 2006年
关键词
wearable sensors; clustering; Parkinson's disease; dyskinesia;
D O I
暂无
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
The aim of this study is to identify, movement characteristics associated with motor fluctuations in patients with Parkinson's disease by relying on wearable sensors. Improved methods of assessing longitudinal changes in Parkinson's disease would enable optimization of treatment and maximization of patient function. We used eight accelerometers on the tipper and lower limbs to monitor patients while they performed a set of standardized motor tasks. A video of the subjects was used by an expert to assign clinical scores. We focused on a motor complication referred to as dyskinesia, which is observed in association with medication intake. The sensor data were processed to extract a feature set responsive to the motor fluctuations. To assess the ability of accelerometers to capture the motor fluctuation patterns, the feature space was visualized using PCA and Sammon's mapping. Clustering analysis revealed the existence of intermediate clusters that were observed when changes occurred in the severity of dyskinesia. We present quantitative evidence that these intermediate clusters are the result of the high sensitivity of the proposed technique to changes in the severity of dyskinesia observed during motorfluctuation cycles.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 12 条
[1]  
BEZDEK JC, 1998, IEEE T SYSTEM MAN B, V28
[2]   Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease [J].
Blanchet, PJ ;
Papa, SM ;
Metman, LV ;
Mouradian, MM ;
Chase, TN .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04) :447-453
[3]  
CHASE TN, 1998, NEUROLOGY S, V50, P17
[4]  
Fahn S, 1987, Recent Dev. Park. Dis, P153
[5]  
Hart, 2006, PATTERN CLASSIFICATI
[6]  
Jollife IT, 1986, PRINCIPAL COMPONENTS
[7]   Parkinson's disease - Second of two parts [J].
Lang, AE ;
Lozano, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (16) :1130-1143
[8]   Parkinson's disease - First of two parts [J].
Lang, AE ;
Lozano, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) :1044-1053
[9]   MODIFICATION OF CENTRAL DOPAMINERGIC MECHANISMS BY CONTINUOUS LEVODOPA THERAPY FOR ADVANCED PARKINSONS-DISEASE [J].
MOURADIAN, MM ;
HEUSER, IJE ;
BARONTI, F ;
CHASE, TN .
ANNALS OF NEUROLOGY, 1990, 27 (01) :18-23
[10]   Levodopa motor complications in Parkinson's disease [J].
Obeso, JA ;
Olanow, CW ;
Nutt, JG .
TRENDS IN NEUROSCIENCES, 2000, 23 (10) :S2-S7